Cargando…

2018 Synaptic vesicle 2 receptors as a novel targets for neuroendocrine cancer therapy

OBJECTIVES/SPECIFIC AIMS: (1) To delineate the function of the heavy-chain receptor binding domain (HCR), a portion of botulinum neurotoxin type A (BoNT/A) and synaptic vesicle 2 (SV2) signaling pathway, which provide a novel multipurpose biologic with potential clinical applications in tumor detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaskula-Sztul, Renata, Whitt, Jason D., Ou, Jianfa, Liu, Margaret X., Aburjania, Zviadi, Chen, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799207/
http://dx.doi.org/10.1017/cts.2018.125

Ejemplares similares